Abstract Background: Mammalian target of rapamycin inhibitors (mTORi) combined with tacrolimus and prednisolone enable tacrolimus dose reduction. This study evaluated everolimus–low-dose tacrolimus–prednisolone (EVR-IS) versus standard myco-phenolate mofetil (MMF)–tacrolimus–prednisolone (MMF-IS) on effector (Teff) and regulatory T cells (Tregs) in elderly kidney transplant recipients.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with van
Contact van, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack